Literature DB >> 9634491

Concepts of oxygen transport at the microcirculatory level.

M W Dewhirst1.   

Abstract

This article compares and contrasts the classic paradigms underlying the development of chronic and acute hypoxia in tumors. The classic theory of Thomlinson and Gray suggested that chronic hypoxia is the result of large intravascular distances. Newer evidence suggests that a multiplicity of effects contribute to this process, including steep longitudinal gradients of partial pressure of oxygen (Po2) along the vascular tree before arteriolar entry into tumor, rheologic effects on red cell deformability brought on by intravascular hypoxia, uneven distribution of red cell fluxes in microvessels leading to plasma channels, irregular vascular geometry, and oxygen demand that is out of balance with the supply. The most common theories have suggested that vascular stasis is the most common source of acute hypoxia. If this were true, the incidence of this form of hypoxia would be relatively rare because most studies indicate that total stasis probably occurs less than 5% of the time. Studies have suggested, however, that spontaneous fluctuation in tumor blood flow, on the microregional level, can lead to tissue hypoxia, and total vascular stasis is not required. Spontaneous fluctuations in flow and Po2 appear to occur commonly. Thus, the most current evidence suggests that tumor oxygenation is in a continuous state of flux. Collectively, this new information has important implications for therapy resistance and gene expression. Copyright 1998 W.B. Saunders Company.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9634491     DOI: 10.1016/s1053-4296(98)80040-4

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  44 in total

Review 1.  Causes and effects of heterogeneous perfusion in tumors.

Authors:  R J Gillies; P A Schornack; T W Secomb; N Raghunand
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

2.  Durable palliation of breast cancer chest wall recurrence with radiation therapy, hyperthermia, and chemotherapy.

Authors:  Timothy M Zagar; Kristin A Higgins; Edward F Miles; Zeljko Vujaskovic; Mark W Dewhirst; Robert W Clough; Leonard R Prosnitz; Ellen L Jones
Journal:  Radiother Oncol       Date:  2010-11-11       Impact factor: 6.280

Review 3.  Hypoxia and fungal pathogenesis: to air or not to air?

Authors:  Nora Grahl; Kelly M Shepardson; Dawoon Chung; Robert A Cramer
Journal:  Eukaryot Cell       Date:  2012-03-23

4.  Functional analysis of selected deletion mutants in Candida glabrata under hypoxia.

Authors:  Payal Gupta; Ramesh Chand Meena; Navin Kumar
Journal:  3 Biotech       Date:  2017-06-29       Impact factor: 2.406

5.  Dynamic contrast-enhanced MR imaging in predicting progression of enhancing lesions persisting after standard treatment in glioblastoma patients: a prospective study.

Authors:  Roh-Eul Yoo; Seung Hong Choi; Tae Min Kim; Chul-Kee Park; Sung-Hye Park; Jae-Kyung Won; Il Han Kim; Soon Tae Lee; Hye Jeong Choi; Sung-Hye You; Koung Mi Kang; Tae Jin Yun; Ji-Hoon Kim; Chul-Ho Sohn
Journal:  Eur Radiol       Date:  2016-12-14       Impact factor: 5.315

Review 6.  Tumor microvasculature and microenvironment: novel insights through intravital imaging in pre-clinical models.

Authors:  Dai Fukumura; Dan G Duda; Lance L Munn; Rakesh K Jain
Journal:  Microcirculation       Date:  2010-04       Impact factor: 2.628

7.  Preclinical validation of the hypoxia tracer 2-(2-nitroimidazol-1-yl)- N-(3,3,3-[(18)F]trifluoropropyl)acetamide, [(18)F]EF3.

Authors:  P Mahy; M De Bast; P H Leveque; J Gillart; D Labar; J Marchand; V Gregoire
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-06-10       Impact factor: 9.236

8.  [18F]EF3 is not superior to [18F]FMISO for PET-based hypoxia evaluation as measured in a rat rhabdomyosarcoma tumour model.

Authors:  Ludwig Dubois; Willy Landuyt; Lieselotte Cloetens; Anne Bol; Guy Bormans; Karin Haustermans; Daniel Labar; Johan Nuyts; Vincent Grégoire; Luc Mortelmans
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08-09       Impact factor: 9.236

Review 9.  Molecular aspects of tumour hypoxia.

Authors:  Saskia E Rademakers; Paul N Span; Johannes H A M Kaanders; Fred C G J Sweep; Albert J van der Kogel; Johan Bussink
Journal:  Mol Oncol       Date:  2008-03-27       Impact factor: 6.603

10.  Methylalpinumisoflavone inhibits hypoxia-inducible factor-1 (HIF-1) activation by simultaneously targeting multiple pathways.

Authors:  Yang Liu; Coothan K Veena; J Brian Morgan; Kaleem A Mohammed; Mika B Jekabsons; Dale G Nagle; Yu-Dong Zhou
Journal:  J Biol Chem       Date:  2008-12-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.